Search

Author/Creator Grove, Richard

13. Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups. (24th June 2022)

Authors:
Rawlings, M Keith; Letang, Emilio; Quercia, Romina; Grove, Richard; DeMasi, Ralph; Min, Sherene; Vannappagari, Vani; Zolopa, Andrew; van Wyk, Jean; Smith, Kimberly
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 8(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies. Issue 1 (9th December 2021)

Authors:
Ait-Khaled, Mounir; Sierra Madero, Juan; Estrada, Vicente; Gulminetti, Roberto; Hagins, Debbie; Tsai, Hung-Chin; Man, Choy; Sievers, Jörg; Grove, Richard; Zolopa, Andrew; Wynne, Brian; van Wyk, Jean
Journal:
HIV research & clinical practice
Issue:
Volume 23:Issue 1(2022)
Page Start:
9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗